Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research

The Lancet Infectious Diseases

Volumn 16, Issue 10, 2016, Pages e202-e213

  Fitchett, Elizabeth J A ^a   Seale, Anna C ^a,b   Vergnano, Stefania ^c   Sharland, Michael ^c   Heath, Paul T ^c   Saha, Samir K ^d   Agarwal, Ramesh ^e   Ayede, Adejumoke I ^f   Bhutta, Zulfiqar A ^g,h   Black, Robert ⁱ   Bojang, Kalifa ^j   Campbell, Harry ^k   Cousens, Simon ^a   Darmstadt, Gary L ^l   Madhi, Shabir A ^m   Meulen, Ajoke Sobanjo ter ⁿ   Modi, Neena ^o,p   Patterson, Janna ⁿ   Qazi, Shamim ^q   Schrag, Stephanie J ^r   Stoll, Barbara J ^s   Wall, Stephen N ^t   Wammanda, Robinson D ^u   Lawn, Joy E ^a   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d DHAKA SHISHU HOSPITAL   (Bangladesh)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^f UNIVERSITY OF IBADAN   (Nigeria)

^g AGA KHAN UNIVERSITY   (Pakistan)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁿ BILL AND MELINDA GATES FOUNDATION   (United States)

^o ROYAL COLLEGE OF PAEDIATRICS AND CHILD HEALTH   (United Kingdom)

^p IMPERIAL COLLEGE LONDON   (United Kingdom)

^q WORLD HEALTH ORGANIZATION   (Switzerland)

^r CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^s CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^t SAVE THE CHILDREN   (United States)

^u AHMADU BELLO UNIVERSITY   (Nigeria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHECKLIST; CLINICAL RESEARCH; CONSENSUS; DISABILITY ADJUSTED LIFE YEARS; EPIDEMIOLOGICAL DATA; HUMAN; MICROBIOLOGICAL EXAMINATION; NEWBORN DEATH; NEWBORN INFECTION; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; CONSENSUS DEVELOPMENT; EPIDEMIOLOGY; GLOBAL HEALTH; INFANT; INFANT MORTALITY; NEWBORN; NEWBORN DISEASE; OBSERVATION; PROCEDURES; STANDARDS;

CHECKLIST; EPIDEMIOLOGIC RESEARCH DESIGN; EPIDEMIOLOGIC STUDIES; GLOBAL HEALTH; GUIDELINES AS TOPIC; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; OBSERVATION;

EID: 84990059410     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30082-2     Document Type: Review

References (60)

1. 1 Lawn, JE, The child survival revolution: what next?. Lancet 384 (2014), 931–933.
2. 2 Lawn, JE, Blencowe, H, Oza, S, et al. Every Newborn 2: progress, priorities, and potential beyond survival. Lancet 384 (2014), 189–205.
3. 3 You, D, Hug, L, Chen, Y, Levels and trends in child mortality. Report 2014. Estimates developed by the UN Inter-agency Group for Child Mortality Estimation. http://www.unicef.org/media/files/Levels_and_Trends_in_Child_Mortality_2014.pdf, 2014 (accessed May 17, 2016).
4. 4 Oza, S, Cousens, SN, Lawn, JE, Estimation of daily risk of neonatal death, including the day of birth, in 186 countries in 2013: a vital-registration and modelling-based study. Lancet Glob Health 2 (2014), e635–e644.
5. 5 WHO. Every newborn—an action plan to end preventable deaths. http://apps.who.int/iris/bitstream/10665/127938/1/97892415%2007448_eng.pdf, 2014 (accessed May 17, 2016).
6. 6 Liu, L, Oza, S, Hogan, D, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385 (2015), 430–440.
7. 7 Lawn, JE, Blencowe, H, Waiswa, P, et al., for the Lancet Ending Preventable Stillbirths Series study group with the Lancet Stillbirth Epidemiology investigator group. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet 387 (2016), 587–603.
8. 8 Seale, AC, Blencowe, H, Manu, AA, et al. Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis 14 (2014), 731–741.
9. 9 Seale, AC, Blencowe, H, Zaidi, A, et al. Neonatal severe bacterial infection impairment estimates in south Asia, sub-Saharan Africa, and Latin America for 2010. Pediatr Res 74:suppl 1 (2013), 73–85.
10. 10 Baqui, AH, Saha, SK, Ahmed, AS, et al. Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trial. Lancet Glob Health 3 (2015), e279–e287.
11. 11 Tshefu, A, Lokangaka, A, Ngaima, S, et al., for the African Neonatal Sepsis Trial (AFRINEST) group. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equvalence trial. Lancet 385 (2015), 1767–1776.
12. 12 Tshefu, A, Lokangaka, A, Ngaima, S, et al., for the African Neonatal Sepsis Trial (AFRINEST) group. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial. Lancet 385 (2015), 1758–1766.
13. 13 Bhutta, ZA, Das, JK, Bahl, R, et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?. Lancet 384 (2014), 347–370.
14. 14 Darmstadt, GL, Stoll, BJ, Zaidi, AKM, Neonatal infections: a global perspective. Wilson, C, Nizet, V, Maldonado, Y, Remington, J, Klein, J, (eds.) Remington and Klein's infectious diseases of the fetus and newborn infant, 8th edn., 2015, Elsevier/Saunders, Philadelphia, PA, 24–53.
15. 15 Meulen, AS, Abramson, J, Mason, E, et al. Path to impact: a report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin—January 29–30, 2015. Vaccine 33 (2015), 6388–6395.
16. 16 Modjarrad, K, Giersing, B, Kaslow, DC, Smith, PG, Moorthy, VS, WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization meeting held on 23–24 March 2015. Vaccine 34 (2016), 190–197.
17. 17 Schrag, SJ, Group B streptococcal vaccine for resource-poor countries. Lancet 378 (2011), 11–12.
18. 18 Seale, AC, Obiero, C, Berkley, JA, Rational development of guidelines for management of neonatal sepsis in developing countries. Curr Opin Infect Dis 28 (2014), 225–230.
19. 19 Murray, CJ, Vos, T, Lozano, R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2197–2223.
20. 20 WHO. Antimicrobial resistance: global report on surveillance. http://www.who.int/drugresistance/documents/surveillancereport/en/, 2014 (accessed May 17, 2016).
21. 21 Herbert, HK, Lee, AC, Chandran, A, Rudan, I, Baqui, AH, Care seeking for neonatal illness in low- and middle-income countries: a systematic review. PLoS Med, 9, 2012, e1001183.
22. 22 Darmstadt, GL, Saha, SK, Choi, Y, et al. Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study. J Infect Dis 127 (2012), 358–366.
23. 23 Thaver, D, Zaidi, AK, Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J 28 (2009), S3–S9.
24. 24 Farzin, A, Saha, S, Bacqui, AH, et al. Population-based incidence and etiology of community-acquired neonatal viral infections in Bangladesh: a community-based and hospital-based surveillance study. Pediatr Infect Dis J 34 (2015), 706–711.
25. 25 Hamer, DH, Darmstadt, GL, Carlin, JB, et al. Etiology of bacteremia in young infants in six countries. Pediatr Infect Dis J 34 (2014), 1–8.
26. 26 Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet 371 (2008), 135–142.
27. 27 WHO. Integrated management of childhood illness: chart booklet. http://apps.who.int/iris/bitstream/10665/104772/16/9789241506823_Chartbook_eng.pdf, 2014 (accessed May 17, 2016).
28. 28 Darmstadt, GL, Baqui, AH, Choi, Y, et al. Validation of a clinical algorithm to identify neonates with severe illness during routine household visits in rural Bangladesh. Arch Dis Child 96 (2011), 1140–1146.
29. 29 von Elm, E, Altman, DG, Egger, M, Pocock, SJ, Gøtzsche, C, Vandenbroucke, JP, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ 85 (2007), 867–872.
30. 30 Moher, D, Jones, A, Lepage, L, Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285 (2001), 1992–1995.
31. 31 Field, N, Cohen, T, Struelens, MJ, et al. Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect Dis 14 (2014), 341–352.
32. 32 Stone, SP, Cooper, BS, Kibbler, CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 7 (2007), 282–288.
33. 33 Saint-Raymond, A, Hill, S, Martines, J, Bahl, R, Fontaine, O, Bero, L, CONSORT 2010. Lancet 376 (2010), 229–230.
34. 34 EQUATOR Network. Reporting guidelines under development. http://www.equator-network.org/library/reporting-guidelines-under-development/ (accessed May 17, 2016).
35. 35 Chalmers, I, Glasziou, P, Avoidable waste in the production and reporting of evidence. Lancet 374 (2009), 86–89.
36. 36 Moher, D, Schulz, KF, Simera, I, Altman, DG, Guidance for developers of health research reporting guidelines. PLoS Med, 7, 2010, e1000217.
37. 37 Folgori, L, Bielicki, J, Sharland, M, A systematic review of strategies for reporting of neonatal hospital-acquired bloodstream infections. Arch Dis Child Fetal Neonatal Ed 98 (2012), F518–F523.
38. 38 Diaz, MH, Waller, JL, Napoliello, RA, et al. Optimization of multiple pathogen detection using the TaqMan array card: application for a population-based study of neonatal infection. PLoS One, 8, 2013, e66183.
39. 39 Levine, OS, O'Brien, KL, Deloria-Knoll, M, et al. The pneumonia etiology research for child health project: a 21st century childhood pneumonia etiology study. Clin Infect Dis 54 (2012), 93–101.
40. 40 Panchalingam, S, Antonio, M, Hossain, A, et al. Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis 55 (2012), 294–302.
41. 41 Emmadi, R, Boonyaratanakornkit, JB, Selvarangan, R, et al. Molecular methods and platforms for infectious diseases testing: a review of FDA-approved and cleared assays. J Mol Diagn 13 (2011), 583–604.
42. 42 Baqui, AH, Arifeen, SE, Williams, EK, et al. Effectiveness of home-based management of newborn infections by community health workers in rural Bangladesh. Pediatr Infect Dis J 28 (2009), 304–310.
43. 43 Maine, D, Bailey, P, Lobis, S, Fortney, J, World Health Organization. Monitoring emergency obstetric care. http://apps.who.int/iris/bitstream/10665/44121/1/9789241547734_eng.pdf, 2009 (accessed May 17, 2016).
44. 44 Seale, AC, Mwaniki, MK, Newton, CR, Berkley, JA, Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis 9 (2009), 428–438.
45. 45 Heath, PT, Balfour, G, Weisner, AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 363 (2004), 292–294.
46. 46 Rupp, M, Archer, G, Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis 19 (1994), 231–243.
47. 47 Chan, GJ, Lee, AC, Baqui, AH, Tan, J, Black, RE, Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis. PLoS Med, 10, 2013, e1001502.
48. 48 Cutland, CL, Schrag, SJ, Zell, ER, et al. Maternal HIV infection and vertical transmission of pathogenic bacteria. Pediatrics 130 (2012), e581–e590.
49. 49 Schuchat, A, Oxtoby, M, Cochi, S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 162 (1990), 672–677.
50. 50 March of Dimes PMNCH Save the Children, WHO. Howson, CP, Kinney, MV, Lawn, JE, (eds.) Born too soon: the global action report on preterm birth, 2012, World Health Organization, Geneva http://apps.who.int/iris/bitstream/10665/44864/1/9789241503433_eng.pdf?ua=1 (accessed Sept 31, 2015).
51. 51 Blencowe, H, Cousens, S, Oestergaard, MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379 (2012), 2162–2172.
52. 52 Ohlsson, A, Shah, V, Intrapartum antibiotics for group B streptococcal colonization. Cochrane Database Syst Rev, 3, 2009 CD007467.
53. 53 Modi, N, Vohra, J, Preston, J, et al. Guidance on clinical research involving infants, children and young people: an update for researchers and research ethics committees. Arch Dis Child 99 (2014), 887–891.
54. 54 Kaiser, MM, Hays, BJ, Recruiting and enrolling pregnant adolescents for research. Issues Compr Pediatr Nurs 29 (2006), 45–52.
55. 55 Hassall, O, Ngina, L, Kongo, W, et al. The acceptability to women in Mombasa, Kenya, of the donation and transfusion of umbilical cord blood for severe anaemia in young children. Vox Sang 94 (2008), 125–131.
56. 56 Blencowe, H, Vos, T, Lee, AC, et al. Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study. Pediatr Res 74:suppl 1 (2013), 4–16.
57. 57 Blencowe, H, Lee, AC, Cousens, S, et al. Preterm birth–associated neurodevelopmental impairment estimates at regional and global levels for 2010. Pediatr Res 74 (2013), 17–34.
58. 58 Mason, E, McDougall, L, Lawn, JE, et al. From evidence to action to deliver a healthy start for the next generation. Lancet 384 (2015), 455–467.
59. 59 WHO. Strategies toward ending preventable maternal mortality (EPMM). http://www.everywomaneverychild.org/images/EPMM_final_report_2015.pdf, 2015 (accessed May 17, 2016).
60. 60 Every Woman Every Child 2015. The global strategy for women's, children's and adolescent's health (2016-2030): survive, thrive, transform. http://globalstrategy.everywomaneverychild.org, 2015 (accessed May 17, 2016).